Bristol Myers Squibb (BMY)

Financing Cash Flow

-$2.63B

Quarterly · Period ending: · USD

BMY logo

BMY Financing Cash Flow

Latest reported-$2.63B
BMY Quarterly Cash from Financing (-$310.00M → -$2.63B)
High-resolution chart · PNG

BMY financing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb Financing Cash Flow — Quarterly (USD)
Period endingFinancing Cash Flow (USD)
-2,630,000,000
-1,560,000,000
-6,029,000,000
-1,490,000,000
-1,836,000,000
-993,000,000
-1,642,000,000
-3,852,000,000
-4,023,000,000
14,644,000,000
967,000,000
-5,160,000,000
-2,173,000,000
-3,050,000,000
-3,246,000,000
-4,543,000,000
-3,520,000,000
-5,653,000,000
-3,967,000,000
-1,780,000,000
-3,182,000,000
-7,295,000,000
3,483,000,000
-2,587,000,000
-993,000,000
-1,054,000,000
-7,677,000,000
-941,000,000
18,268,000,000
-2,029,000,000
-578,000,000
-720,000,000
-1,015,000,000
-1,222,000,000
-1,352,000,000
-706,000,000
-1,006,000,000
-1,013,000,000
-590,000,000
-546,000,000
-552,000,000
-950,000,000
-1,086,000,000
-700,000,000
-883,000,000
-682,000,000
-231,000,000
-528,000,000
-486,000,000
-1,192,000,000
711,000,000
-620,000,000
-1,115,000,000
-44,000,000
-958,000,000
-1,689,000,000
-850,000,000
-836,000,000
-754,000,000
-704,000,000
-507,000,000
-692,000,000
-1,664,000,000
-698,000,000
-495,000,000
-486,000,000
994,000,000
-656,000,000
-710,000,000
355,000,000
-603,000,000
-2,214,000,000
969,000,000
-734,000,000
-524,000,000
-1,844,000,000
-264,000,000
-581,000,000
-1,775,000,000
-604,000,000
-587,000,000
-385,000,000
1,925,000,000
-515,000,000
-3,001,000,000
-2,074,000,000
-406,000,000
110,000,000
-327,000,000
120,000,000
-514,000,000
-92,000,000
-891,000,000
445,000,000
40,000,000
-602,000,000
-117,000,000
-438,000,000
-2,337,000,000
6,316,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.